NLRP12 and glomerulosclerosis: The Nlrp12–/–/lpr mice exhibited further progression to glomerular sclerosis, with 7.3% of glomeruli showing complete sclerosis during the ninth month (score 5), revealing the acceleration of disease activity under NLRP12 deficiency.